Cellular Technology Limited
Magdalena Tary-Lehmann, M.D., Ph.D. has a wealth of experience in the medical field. Starting in 1989, they were a Postdoctoral Fellow in the Department of Medicine, Division of Clinical Immunology and Allergy at UCLA. From 1993 to 1998, they held various positions at Case Western Reserve University, including Associate Professor of Pathology, Assistant Professor in the Department of Pathology, and Instructor in the Department of Pathology. In 1998, they co-founded Cellular Technology Limited, where they serve as Chief Scientific Officer and Treasurer. In this role, they provide guidance and oversight for technical operations, performs regulated immunology assays in CTL’s GLP- and CLIA compliant laboratory, and provides scientific expertise in the development and validation of reference samples.
Magdalena Tary-Lehmann, M.D., Ph.D. obtained their Ph.D. in Immunology from the University of Tubingen, Freiburg, Germany in 1993 and their M.D. in Medicine from the same institution in 1988.
Cellular Technology Limited
Cellular Technology Limited (CTL) has been pioneering the ELISPOT technology for immune monitoring. For nearly 20 years, CTL’s mission has been “Elevating ELISPOT to an Exact Science”. Serving over 2,000 clients from academia and industry worldwide, CTL offers unparalleled expertise in immune monitoring